Maravai LifeSciences Q1 2026 Earnings EPS Surprise Beats Street but Stock Slips Amid Revenue Disclosures SEE Q4 2025 Earnings EPS Beats Estimates by 428 as Operational Efficiency Drives Results Tonix Pharmaceuticals Q1 2026 Earnings WiderThanExpected Loss Compounds Investor Concerns Hennessy Advisors Q1 2026 Earnings EPS of 024 Reported Bond Price Edges Lower VRE Q4 2025 Earnings EPS Surprises to the Upside Despite Loss Stock Virtually Flat Kirby Corporation Q1 2026 Earnings EPS Beat Drives Positive Sentiment